179 related articles for article (PubMed ID: 34081128)
1. Diminished Hepatocarcinogenesis by a Potent, High-Affinity Human PPARα Agonist in PPARA-Humanized Mice.
Foreman JE; Koga T; Kosyk O; Kang BH; Zhu X; Cohen SM; Billy LJ; Sharma AK; Amin S; Gonzalez FJ; Rusyn I; Peters JM
Toxicol Sci; 2021 Aug; 183(1):70-80. PubMed ID: 34081128
[TBL] [Abstract][Full Text] [Related]
2. Species Differences between Mouse and Human PPARα in Modulating the Hepatocarcinogenic Effects of Perinatal Exposure to a High-Affinity Human PPARα Agonist in Mice.
Foreman JE; Koga T; Kosyk O; Kang BH; Zhu X; Cohen SM; Billy LJ; Sharma AK; Amin S; Gonzalez FJ; Rusyn I; Peters JM
Toxicol Sci; 2021 Aug; 183(1):81-92. PubMed ID: 34081146
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of Linoleic Acid by Altered Peroxisome Proliferator-Activated Receptor-α Signaling Is Associated with Age-Dependent Hepatocarcinogenesis in
Zhu X; Liu Q; Patterson AD; Sharma AK; Amin SG; Cohen SM; Gonzalez FJ; Peters JM
Metabolites; 2023 Aug; 13(8):. PubMed ID: 37623879
[TBL] [Abstract][Full Text] [Related]
4. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
[TBL] [Abstract][Full Text] [Related]
5. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.
Xie C; Takahashi S; Brocker CN; He S; Chen L; Xie G; Jang K; Gao X; Krausz KW; Qu A; Levi M; Gonzalez FJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1396-1411. PubMed ID: 31195146
[TBL] [Abstract][Full Text] [Related]
7. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
[TBL] [Abstract][Full Text] [Related]
8. Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha.
Li G; Brocker CN; Yan T; Xie C; Krausz KW; Xiang R; Gonzalez FJ
Mol Metab; 2018 Jan; 7():80-89. PubMed ID: 29146411
[TBL] [Abstract][Full Text] [Related]
9. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.
Morimura K; Cheung C; Ward JM; Reddy JK; Gonzalez FJ
Carcinogenesis; 2006 May; 27(5):1074-80. PubMed ID: 16377806
[TBL] [Abstract][Full Text] [Related]
10. Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis.
Yan T; Luo Y; Yan N; Hamada K; Zhao N; Xia Y; Wang P; Zhao C; Qi D; Yang S; Sun L; Cai J; Wang Q; Jiang C; Gavrilova O; Krausz KW; Patel DP; Yu X; Wu X; Hao H; Liu W; Qu A; Gonzalez FJ
Hepatology; 2023 Jan; 77(1):239-255. PubMed ID: 35460276
[TBL] [Abstract][Full Text] [Related]
11. Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643.
Li G; Brocker CN; Xie C; Yan T; Noguchi A; Krausz KW; Xiang R; Gonzalez FJ
J Gastroenterol Hepatol; 2018 May; 33(5):1138-1145. PubMed ID: 29141109
[TBL] [Abstract][Full Text] [Related]
12. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
13. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.
Li HH; Tyburski JB; Wang YW; Strawn S; Moon BH; Kallakury BV; Gonzalez FJ; Fornace AJ
Alcohol Clin Exp Res; 2014 Jun; 38(6):1520-31. PubMed ID: 24773203
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyocyte peroxisome proliferator-activated receptor α prevents septic cardiomyopathy via improving mitochondrial function.
Zhu XX; Wang X; Jiao SY; Liu Y; Shi L; Xu Q; Wang JJ; Chen YE; Zhang Q; Song YT; Wei M; Yu BQ; Fielitz J; Gonzalez FJ; Du J; Qu AJ
Acta Pharmacol Sin; 2023 Nov; 44(11):2184-2200. PubMed ID: 37328648
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte Peroxisome Proliferator-Activated Receptor α Enhances Liver Regeneration after Partial Hepatectomy in Mice.
Xie G; Yin S; Zhang Z; Qi D; Wang X; Kim D; Yagai T; Brocker CN; Wang Y; Gonzalez FJ; Wang H; Qu A
Am J Pathol; 2019 Feb; 189(2):272-282. PubMed ID: 30448405
[TBL] [Abstract][Full Text] [Related]
16. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
17. A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists.
Patil R; Mohanty B; Liu B; Chandrashekaran IR; Headey SJ; Williams ML; Clements CS; Ilyichova O; Doak BC; Genissel P; Weaver RJ; Vuillard L; Halls ML; Porter CJH; Scanlon MJ
J Biol Chem; 2019 Mar; 294(10):3720-3734. PubMed ID: 30598509
[TBL] [Abstract][Full Text] [Related]
18. PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis.
Hu X; Tanaka N; Guo R; Lu Y; Nakajima T; Gonzalez FJ; Aoyama T
J Nutr Biochem; 2017 Jan; 39():77-85. PubMed ID: 27816763
[TBL] [Abstract][Full Text] [Related]
19. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.
Stec DE; Gordon DM; Hipp JA; Hong S; Mitchell ZL; Franco NR; Robison JW; Anderson CD; Stec DF; Hinds TD
Am J Physiol Regul Integr Comp Physiol; 2019 Nov; 317(5):R733-R745. PubMed ID: 31483154
[TBL] [Abstract][Full Text] [Related]
20. Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).
Howroyd P; Swanson C; Dunn C; Cattley RC; Corton JC
Toxicol Pathol; 2004; 32(5):591-9. PubMed ID: 15603543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]